Treatment of fistulizing inflammatory bowel disease

Gastroenterology Clinics of North America
David A Schwartz, Brad E Maltz

Abstract

Fistulas manifest frequently in Crohn disease and can result in significant morbidity and often lead to the need for surgical intervention. Historically, it has been more difficult to obtain complete fistula closure in patients with perianal Crohn disease. Anti-tumor necrosis factor-alpha agents and the use of more accurate imaging modalities such as magnetic resonance imaging and rectal endoscopic ultrasound have enhanced the ability to manage fistulizing Crohn disease. A combined medical and surgical approach usually presents the best option for most patients.

References

Oct 1, 1992·Diseases of the Colon and Rectum·L E Hughes
Feb 1, 1991·Diseases of the Colon and Rectum·R I WeismanH Abcarian
Oct 1, 1989·Diseases of the Colon and Rectum·G M Fuhrman, S W Larach
Feb 1, 1985·Diseases of the Colon and Rectum·H C Kuijpers, T Schulpen
Aug 1, 1985·Diseases of the Colon and Rectum·R E GlassI P Todd
Feb 1, 1983·AJR. American Journal of Roentgenology·H I GoldbergE L Baker
Apr 1, 1995·Diseases of the Colon and Rectum·P R WilliamsonA Ferrara
Oct 1, 1994·Journal of Clinical Gastroenterology·A LavyS Eidelman
Jul 1, 1994·Diseases of the Colon and Rectum·P J LunnissR K Phillips
Aug 1, 1994·Diseases of the Colon and Rectum·I Bayer, P H Gordon
May 1, 1993·Diseases of the Colon and Rectum·M E AbelP A Volpe
Nov 1, 1995·Gut·F MakowiecM Starlinger
Apr 1, 1997·Diseases of the Colon and Rectum·F MakowiecM Starlinger
Apr 22, 1999·Diseases of the Colon and Rectum·T YamamotoM R Keighley
Dec 10, 1999·American Journal of Surgery·N Hyman
Jul 26, 2000·Diseases of the Colon and Rectum·J R CintronH Abcarian
Nov 5, 2003·Gastroenterology·UNKNOWN American Gastroenterological Association Clinical Practice Committee
Nov 5, 2003·Gastroenterology·William J SandbornUNKNOWN American Gastroenterological Association Clinical Practice Committee
Jan 28, 2005·Inflammatory Bowel Diseases·Yago González-LamaPedro Escartin
Aug 20, 2005·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·S J van der HagenW G van Gemert
May 9, 2007·Gastroenterology·Stephan R TarganUNKNOWN International Efficacy of Natalizumab in Crohn's Disease Response and Remission (ENCORE) Trial Group
Sep 11, 2007·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·K SongneP Ténière
Oct 27, 2007·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·J G WilliamsB D George
Mar 12, 2008·Diseases of the Colon and Rectum·Alex J KyErin K Ly

❮ Previous
Next ❯

Citations

Apr 6, 2011·Folia medica·Bozhidar D Hadzhiev, Mariana A Murdjeva
Feb 1, 2017·The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi·Jae Jun ParkUNKNOWN IBD Study Group of the Korean Association for the Study of the Intestinal Diseases
Feb 28, 2017·Intestinal research·Jae Jun ParkUNKNOWN IBD Study Group of the Korean Association for the Study of Intestinal Diseases
Feb 24, 2012·Journal of Pediatric Gastroenterology and Nutrition·David N LevinJacob C Langer
Jul 29, 2016·Journal of Clinical Gastroenterology·Pavlos KaimakliotisParis P Tekkis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.